Literature DB >> 24375820

Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.

Mariem Ben Hamad1, Sameh Marzouk, Neila Kaddour, Hatem Masmoudi, Faiza Fakhfakh, Ahmed Rebai, Zouhir Bahloul, Abdellatif Maalej.   

Abstract

OBJECTIVE: To explore relationships between immunological status, clinical features, radiographic damage, disease activity, and functional disability in Tunisian patients with rheumatoid arthritis (RA).
MATERIALS AND METHODS: The study was carried out in 112 patients with RA. Demographic characteristics, disease duration, disease activity score 28 (DAS28), the Health Assessment Questionnaire (HAQ), and the Sharp/van der Heijde score were collected. Anticyclic citrullinated peptide antibody (anti-CCP) and rheumatoid factor (RF) were performed.
RESULTS: We found that anti-CCP positivity was associated with longer disease duration (P = 0.001), presence of RF (P = 4.89 × 10(-8) ), and night pain positivity (P = 0.025). Patients with positive RF had more night pain and higher anti-CCP positivity (for all P ≤ 0.05). Anti-CCP titer was correlated with disease duration (P = 0.034) and Sharp total score (P = 1.2 × 10(-4) ). Moreover, there was a significant correlation between RF and anti-CCP antibodies titers (P = 0.011). Indeed, DAS28 correlated with HAQ (P = 1.8 × 10(-7) ) and morning stiffness duration (P = 0.045). In multivariate regression analysis, the main factors associated with anti-CCP titers were radiographic damage (P = 1.625 × 10(-4) ) and RF (P = 0.013). For DAS28, only HAQ (P = 2.9 × 10(-4) ) was associated.
CONCLUSION: These findings suggest that anti-CCP antibodies are associated with RF and more severe joint damage. Moreover, disease activity is associated with functional disability.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DAS28; anti-CCP antibodies; rheumatoid arthritis; rheumatoid factor

Mesh:

Substances:

Year:  2013        PMID: 24375820      PMCID: PMC6807450          DOI: 10.1002/jcla.21638

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  45 in total

1.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.

Authors:  E Girbal-Neuhauser; J J Durieux; M Arnaud; P Dalbon; M Sebbag; C Vincent; M Simon; T Senshu; C Masson-Bessière; C Jolivet-Reynaud; M Jolivet; G Serre
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

2.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

3.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

4.  Development of a disease activity score based on judgment in clinical practice by rheumatologists.

Authors:  D M van der Heijde; M van 't Hof; P L van Riel; L B van de Putte
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

5.  [The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study].

Authors:  Gracia María Abalos Medina; Gonzalo Ruiz Villaverde; Daniel Sánchez Cano; Ricardo Ruiz Villaverde; Jesús Ramírez Rodrigo; Enrique Raya Álvarez; Carmen Villaverde Gutiérrez
Journal:  Reumatol Clin       Date:  2011-01-22

6.  Consistency of morning stiffness: an analysis of diary data.

Authors:  J M Hazes; R Hayton; J Burt; A J Silman
Journal:  Br J Rheumatol       Date:  1994-06

7.  Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Authors:  K Forslind; M Ahlmén; K Eberhardt; I Hafström; B Svensson
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

8.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

Authors:  F A van Gaalen; S P Linn-Rasker; W J van Venrooij; B A de Jong; F C Breedveld; C L Verweij; R E M Toes; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2004-03

Review 9.  Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.

Authors:  Martinus A M van Boekel; Erik R Vossenaar; Frank H J van den Hoogen; Walther J van Venrooij
Journal:  Arthritis Res       Date:  2001-11-06

Review 10.  Autoantibodies in rheumatoid arthritis and their clinical significance.

Authors:  Günter Steiner; Josef Smolen
Journal:  Arthritis Res       Date:  2002-04-26
View more
  2 in total

1.  Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.

Authors:  José Félix Restrepo; Inmaculada del Rincón; Daniel F Battafarano; Roy W Haas; Merced Doria; Agustín Escalante
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

2.  The TNFA -857C/T Polymorphism: Association with Rheumatoid Arthritis and Anti-CCP Levels in a Mexican Population.

Authors:  Juan Manuel Agraz-Cibrián; Gabriela Nohemí Espinoza-De León; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez; Liliana Ortiz-Martínez; Alejandro Vázquez-Reyes; Jorge Gutiérrez-Franco; Miriam Fabiola Ayón-Pérez; José Francisco Zambrano-Zaragoza
Journal:  J Immunol Res       Date:  2019-10-09       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.